CytomX Therapeutics Shares Outstanding 2014-2022 | CTMX

CytomX Therapeutics shares outstanding from 2014 to 2022. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
CytomX Therapeutics Annual Shares Outstanding
(Millions of Shares)
2021 64
2020 46
2019 45
2018 42
2017 37
2016 36
2015 9
2014 1
2013 1
CytomX Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
2022-06-30 66
2022-03-31 65
2021-12-31 64
2021-09-30 65
2021-06-30 65
2021-03-31 61
2020-12-31 46
2020-09-30 46
2020-06-30 46
2020-03-31 47
2019-12-31 45
2019-09-30 45
2019-06-30 45
2019-03-31 45
2018-12-31 42
2018-09-30 44
2018-06-30 39
2018-03-31 39
2017-12-31 37
2017-09-30 37
2017-06-30 37
2017-03-31 37
2016-12-31 36
2016-09-30 36
2016-06-30 36
2016-03-31 36
2015-12-31 9
2015-09-30 1
2015-06-30 1
2015-03-31 1
2014-12-31
2014-09-30 1
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.096B $0.070B
CytomX Therapeutics, Inc. is an oncology focused biopharmaceutical company. The Company is engaged in developing Probody(TM) therapeutics for the treatment of cancer. Its pipeline focuses areas consist of Precision cancer immunotherapy and Probody drug conjugates. CytomX Therapeutics, Inc. is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $151.795B 9.21
GSK (GSK) United Kingdom $59.851B 7.19
Bio-Rad Laboratories (BIO.B) United States $12.433B 27.47
Biohaven Pharmaceutical Holding (BHVN) United States $10.831B 0.00
QIAGEN (QGEN) Netherlands $9.374B 15.70
Ginkgo Bioworks Holdings (DNA) United States $5.569B 0.00
Arcus Biosciences (RCUS) United States $1.888B 36.85
Myovant Sciences (MYOV) United Kingdom $1.723B 0.00
Emergent Biosolutions (EBS) United States $1.047B 6.07
ADC Therapeutics SA (ADCT) Switzerland $0.370B 0.00
Zymeworks (ZYME) Canada $0.356B 0.00
Enzo Biochem (ENZ) United States $0.109B 0.00
Gelesis Holdings (GLS) United States $0.078B 0.00
SQZ Biotechnologies (SQZ) United States $0.067B 0.00
Ambrx Biopharma (AMAM) United States $0.042B 0.00